http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1301315-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 1983-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1987-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7460d4689703388e89196790e89c8827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f2309b08e0706f2d9cffc5f4da7d1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa48c224c91feb5b865f7f951cab043 |
| publicationDate | 1987-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1301315-A3 |
| titleOfInvention | Method for producing 1h-pyrazole (1,5-a) pyrimidine derivatives or salts thereof (versions) |
| abstract | Compounds of the formula (I) <IMAGE> (I) wherein R1 is: (a) hydrogen, or C1-C6 alkyl; (b) an unsubstituted 2-pyridyl or 3-pyridyl group; (c) a benzyl group, wherein the phenyl ring is unsubstituted or substituted by halogen, C1-C6 alkoxy or C1-C6 alkyl; (d) a phenyl ring, unsubstituted or substituted by one or two groups chosen from halogen, trihalomethyl, C1-C6 alkoxy, C1-C6 alkyl, C2-C6 alkanoylamino, nitro and amino; each of R2 and R3 independently represents hydrogen, halogen or C1-C6 alkyl; R4 represents a 2-pyridyl, 3-pyridyl or 4-pyridyl group, unsubstituted or substituted by C1-C6 alkyl; and the pharmaceutically acceptable salts thereof are disclosed. The compounds have activity in the gastroenteric system, particularly anti-ulcerogenic and gastric anti-secretory activity. Additionally, the compounds have activity in reducing the undesired gastrointestinal side-effects resulting from systemic administration of anti-inflammatory prostaglandin synthetase inhibitors. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2503655-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2450005-C2 |
| priorityDate | 1982-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.